New Caledonia vs Tuvalu: The number of people with susceptibility test result for rifampicin
New Caledonia
15
in 2021
Tuvalu
19
in 2021
New Caledonia rank
135th
Tuvalu rank
133rd
The number of people with susceptibility test result for rifampicin over time
- New Caledonia
- Tuvalu
How they compare
Tuvalu currently reports 19 against 15 in New Caledonia, a difference of 4.
That makes Tuvalu's figure about 1.3 times New Caledonia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was New Caledonia ahead.
New Caledonia ranks 135th and Tuvalu ranks 133rd of 155 countries.
New Caledonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Caledonia | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.33 | 14 | 7.33 | New Caledonia |
| 2020s | 19.5 | 17 | 2.5 | New Caledonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, New Caledonia or Tuvalu?
- Tuvalu, at 19 against 15 in New Caledonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between New Caledonia and Tuvalu?
- 4, with Tuvalu ahead.
- How many years of comparable data are there for New Caledonia and Tuvalu?
- 5 years are reported by both, from 2017 to 2021.
- How do New Caledonia and Tuvalu rank globally for the number of people with susceptibility test result for rifampicin?
- New Caledonia ranks 135th and Tuvalu ranks 133rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.